Rituxan 500 MG/50 ML vial 50ML
Ended Awarded
- Contract number
- SPE2DB25FDM48
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,792
Award facts
- Contract value 100% obligated
- $17,792.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order from the Defense Logistics Agency valued at $17,792.34 for Rituxan 500 mg/50 mL vials. The contract, awarded on September 29, 2025, with an ultimate completion date of October 21, 2025, represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program. This delivery order carries no set-aside designation, allowing the company to compete on its merits as an established federal pharmaceutical supplier. The place of performance is listed as Park Ridge, Illinois, where the vendor maintains its primary operations.
This award exemplifies DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, particularly for Department of Defense healthcare facilities. The underlying IDC, valued at $499,999,999 and valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide. Rituxan, a branded biologic medication, represents the type of specialty pharmaceutical product covered under this expansive contract vehicle, which encompasses prescription drugs, biologics, over-the-counter medications, and medical consumables across multiple product categories and therapeutic areas.
Quick answers
Who was awarded contract SPE2DB25FDM48?
SPE2DB25FDM48 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FDM48 worth?
The government has obligated $17,792 on SPE2DB25FDM48.
Is contract SPE2DB25FDM48 an order under another contract?
Yes. SPE2DB25FDM48 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDM48 competed?
The extent of competition for SPE2DB25FDM48 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award